Resumo

HANO GARCIA, Olga Marina; OJEDA ABIZAID, Yirian Tatiana; GONZALEZ FABIAN, Licet  e  SANCHEZ RODRIGUEZ, Yoan Antonio. Hepatobiliary manifestations in patients with chronic inflammatory bowel disease. Rev Cubana Invest Bioméd [online]. 2012, vol.31, n.4, pp.490-500. ISSN 0864-0300.

It is common for patients with inflammatory bowel disease to present analytical or clinical changes pointing to the presence of hepatobiliary disease. The frequency of such findings ranges between 11-49 % in ulcerous colitis and between 15-30 % in Crohn's disease. In some cases, the alterations are found when the patient is first examined, while in others they emerge during the course of the disease. An observational retrospective descriptive study was conducted of 180 patients with inflammatory bowel disease cared for at the Institute of Gastroenterology. Hepatobiliary manifestations were found in 17 patients (9.4 %): 12 with ulcerous colitis and 5 with Crohn's disease. The variables studied were sex, age, years of evolution by type of inflammatory disease, type of hepatobiliary manifestation, clinical symptoms, study of hepatic enzymes and ultrasonographic findings. There was a predominance of patients with ulcerous colitis. Female sex prevailed in ulcerous colitis. No significant differences were found in Crohn's disease. Age ranged between 30-49. The most common hepatobiliary manifestations were liver disease of unknown etiology in Crohn's disease and primary sclerosing cholangitis in ulcerous colitis. The prevailing clinical symptom in both groups was asthenia. Pruritus and jaundice were also predominant in ulcerous colitis. With respect to biochemical enzymes, there was a predominance of hypertransaminasemia. Ultrasonographically, a granular aspect and increased hepatic echogenicity were the prevailing features.

Palavras-chave : hepatobiliary manifestation; inflammatory bowel disease; jaundice; pruritus; hypertransaminasemia.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )